Illumina, the maker of DNA sequencers, unveiled its latest device with a price tag of just under $20,000.
TAI will use the cash to advance the cell-free DNA transplant monitoring technology that attracted United Therapeutics.
The partners will create a joint fund that invests in technologies globally and then seeks to accelerate their progress in China.
The partners plan to introduce joint-branded dashboards that pool data generated by their in vitro diagnostics and medical scanners.
AstraZeneca and Myriad Genetics are partnering to identify women with advanced ovarian cancer who might benefit from treatments using Lynparza and Avastin as…
GenScript is adding new synthetic biology chops in areas such as CRISPR through its buyout of CustomArray.
Zimmer Biomet named Bryan Hanson, an executive at rival devicemaker Medtronic, as its new president and chief executive.
The onetime cancer diagnostics pioneer settled for a takeout offer below its share price, resulting in its stock sliding once the news emerged.
The agreement supports Roche’s drive to develop IHC assays that enable doctors to identify patients with NTRK gene rearrangements.
Siemens Healthineers is buying Fast Track Diagnostics, a maker of diagnostics that can distinguish between viral, bacterial or other infections.